541 related articles for article (PubMed ID: 32283359)
1. Methylparaben in meconium and risk of maternal thyroid dysfunction, adverse birth outcomes, and Attention-Deficit Hyperactivity Disorder (ADHD).
Baker BH; Wu H; Laue HE; Boivin A; Gillet V; Langlois MF; Bellenger JP; Baccarelli AA; Takser L
Environ Int; 2020 Jun; 139():105716. PubMed ID: 32283359
[TBL] [Abstract][Full Text] [Related]
2. Association of Prenatal Acetaminophen Exposure Measured in Meconium With Risk of Attention-Deficit/Hyperactivity Disorder Mediated by Frontoparietal Network Brain Connectivity.
Baker BH; Lugo-Candelas C; Wu H; Laue HE; Boivin A; Gillet V; Aw N; Rahman T; Lepage JF; Whittingstall K; Bellenger JP; Posner J; Takser L; Baccarelli AA
JAMA Pediatr; 2020 Nov; 174(11):1073-1081. PubMed ID: 32986124
[TBL] [Abstract][Full Text] [Related]
3. Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age.
Wang Z; Chan AYL; Coghill D; Ip P; Lau WCY; Simonoff E; Brauer R; Wei L; Wong ICK; Man KKC
JAMA Intern Med; 2021 Oct; 181(10):1332-1340. PubMed ID: 34398171
[TBL] [Abstract][Full Text] [Related]
4. Maternal Mild Thyroid Hormone Insufficiency in Early Pregnancy and Attention-Deficit/Hyperactivity Disorder Symptoms in Children.
Modesto T; Tiemeier H; Peeters RP; Jaddoe VW; Hofman A; Verhulst FC; Ghassabian A
JAMA Pediatr; 2015 Sep; 169(9):838-45. PubMed ID: 26146876
[TBL] [Abstract][Full Text] [Related]
5. Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder in Offspring.
Sujan AC; Rickert ME; Öberg AS; Quinn PD; Hernández-Díaz S; Almqvist C; Lichtenstein P; Larsson H; D'Onofrio BM
JAMA; 2017 Apr; 317(15):1553-1562. PubMed ID: 28418479
[TBL] [Abstract][Full Text] [Related]
6. The association between prenatal perfluoroalkyl substance exposure and symptoms of attention-deficit/hyperactivity disorder in 8-year-old children and the mediating role of thyroid hormones in the Hokkaido study.
Itoh S; Yamazaki K; Suyama S; Ikeda-Araki A; Miyashita C; Ait Bamai Y; Kobayashi S; Masuda H; Yamaguchi T; Goudarzi H; Okada E; Kashino I; Saito T; Kishi R
Environ Int; 2022 Jan; 159():107026. PubMed ID: 34890903
[TBL] [Abstract][Full Text] [Related]
7. The impact of gestational thyroid hormone concentrations on ADHD symptoms of the child.
Päkkilä F; Männistö T; Pouta A; Hartikainen AL; Ruokonen A; Surcel HM; Bloigu A; Vääräsmäki M; Järvelin MR; Moilanen I; Suvanto E
J Clin Endocrinol Metab; 2014 Jan; 99(1):E1-8. PubMed ID: 24384024
[TBL] [Abstract][Full Text] [Related]
8. Maternal Hypothyroidism Increases the Risk of Attention-Deficit Hyperactivity Disorder in the Offspring.
Peltier MR; Fassett MJ; Chiu VY; Getahun D
Am J Perinatol; 2021 Jan; 38(2):191-201. PubMed ID: 33086392
[TBL] [Abstract][Full Text] [Related]
9. Gestational thyroid hormone concentrations and risk of attention-deficit hyperactivity disorder in the Norwegian Mother, Father and Child Cohort Study.
Engel SM; Villanger GD; Herring A; Nethery RC; Drover SSM; Zoeller RT; Meltzer HM; Zeiner P; Knudsen GP; Reichborn-Kjennerud T; Longnecker MP; Aase H
Paediatr Perinat Epidemiol; 2023 Mar; 37(3):218-228. PubMed ID: 36482860
[TBL] [Abstract][Full Text] [Related]
10. Association of maternal levothyroxine use during pregnancy with offspring birth and neurodevelopmental outcomes: a population-based cohort study.
Ge GM; Cheung ECL; Man KKC; Ip P; Leung WC; Li GHY; Kung AWC; Cheung CL; Wong ICK
BMC Med; 2022 Nov; 20(1):390. PubMed ID: 36344981
[TBL] [Abstract][Full Text] [Related]
11. Attention-deficit hyperactivity disorder in children born to mothers with infertility: a population-based cohort study.
Fine A; Dayan N; Djerboua M; Pudwell J; Fell DB; Vigod SN; Ray JG; Velez MP
Hum Reprod; 2022 Aug; 37(9):2126-2134. PubMed ID: 35670758
[TBL] [Abstract][Full Text] [Related]
12. Association of Timing and Duration of Prenatal Analgesic Opioid Exposure With Attention-Deficit/Hyperactivity Disorder in Children.
Trønnes JN; Lupattelli A; Handal M; Skurtveit S; Ystrom E; Nordeng H
JAMA Netw Open; 2021 Sep; 4(9):e2124324. PubMed ID: 34524436
[TBL] [Abstract][Full Text] [Related]
13. Maternal Benzodiazepines and Z-Drugs Use during Pregnancy and Adverse Birth and Neurodevelopmental Outcomes in Offspring: A Population-Based Cohort Study.
Chan AYL; Gao L; Howard LM; Simonoff E; Coghill D; Ip P; Lau WCY; Taxis K; Wong ICK; Man KKC
Psychother Psychosom; 2023; 92(2):113-123. PubMed ID: 36907183
[TBL] [Abstract][Full Text] [Related]
14. Maternal thyroid dysfunction during gestation, preterm delivery, and birthweight. The Infancia y Medio Ambiente Cohort, Spain.
León G; Murcia M; Rebagliato M; Álvarez-Pedrerol M; Castilla AM; Basterrechea M; Iñiguez C; Fernández-Somoano A; Blarduni E; Foradada CM; Tardón A; Vioque J
Paediatr Perinat Epidemiol; 2015 Mar; 29(2):113-22. PubMed ID: 25565408
[TBL] [Abstract][Full Text] [Related]
15. The relationship between persistent organic pollutants and Attention Deficit Hyperactivity Disorder phenotypes: Evidence from task-based neural activity in an observational study of a community sample of Canadian mother-child dyads.
Sussman TJ; Baker BH; Wakhloo AJ; Gillet V; Abdelouahab N; Whittingstall K; Lepage JF; St-Cyr L; Boivin A; Gagnon A; Baccarelli AA; Takser L; Posner J
Environ Res; 2022 Apr; 206():112593. PubMed ID: 34951987
[TBL] [Abstract][Full Text] [Related]
16. Association of Gestational Age at Birth With Symptoms of Attention-Deficit/Hyperactivity Disorder in Children.
Ask H; Gustavson K; Ystrom E; Havdahl KA; Tesli M; Askeland RB; Reichborn-Kjennerud T
JAMA Pediatr; 2018 Aug; 172(8):749-756. PubMed ID: 29946656
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy exposure to organophosphate esters and the risk of attention-deficit hyperactivity disorder in the Norwegian mother, father and child cohort study.
Choi G; Keil AP; Richardson DB; Daniels JL; Hoffman K; Villanger GD; Sakhi AK; Thomsen C; Reichborn-Kjennerud T; Aase H; Engel SM
Environ Int; 2021 Sep; 154():106549. PubMed ID: 33910116
[TBL] [Abstract][Full Text] [Related]
18. Maternal age at birth and child attention-deficit hyperactivity disorder: causal association or familial confounding?
Baker BH; Joo YY; Park J; Cha J; Baccarelli AA; Posner J
J Child Psychol Psychiatry; 2023 Feb; 64(2):299-310. PubMed ID: 36440655
[TBL] [Abstract][Full Text] [Related]
19. Association of maternal attention deficit hyperactivity disorder and preterm birth: a cohort study.
Hesselman S; Wikman A; Skoglund C; Kopp Kallner H; Skalkidou A; Sundström-Poromaa I; Wikström AK
BJOG; 2020 Nov; 127(12):1480-1487. PubMed ID: 32384173
[TBL] [Abstract][Full Text] [Related]
20. Maternal urinary concentrations of pyrethroid and chlorpyrifos metabolites and attention deficit hyperactivity disorder (ADHD) symptoms in 2-4-year-old children from the Odense Child Cohort.
Dalsager L; Fage-Larsen B; Bilenberg N; Jensen TK; Nielsen F; Kyhl HB; Grandjean P; Andersen HR
Environ Res; 2019 Sep; 176():108533. PubMed ID: 31229776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
